2026 Interim report
Filed with HKEX · Stock code 9637 · · 65 pages · English
Alebund Pharmaceuticals (Jiangsu) Limited on 6ix
Earlier from Alebund Pharmaceuticals (Jiangsu)
- Alebund's AP301 NDA Accepted for Review by China's NMPA
- Announcement of final offer price and allotment results
- List of directors and their roles and functions
- Documents on Display
- PHIP (1st submission)
Later from Alebund Pharmaceuticals (Jiangsu)
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
- Voluntary announcement - on-market share repurchase
Follow Alebund Pharmaceuticals (Jiangsu) into a list and get an email when it puts out news.
Follow Alebund Pharmaceuticals (Jiangsu)